Acceder

Bibliografías temáticas / Leigh disease / Artículos de revistas

Artículos de revistas sobre el tema "Leigh disease"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Leigh disease.

Autor: Grafiati

Publicado: 4 de junio de 2021

Última modificación: 9 de febrero de 2022

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Leigh disease".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Taccone, Agostino, Maia Di Rocco, Paola Fondelli y Franco Cottafava. "Leigh Disease". Journal of Computer Assisted Tomography 13, n.º 2 (marzo de 1989): 207–10. http://dx.doi.org/10.1097/00004728-198903000-00003.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

Coker, Steven B. y Chinnamma Thomas. "Connatal Leigh Disease". Clinical Pediatrics 34, n.º 7 (julio de 1995): 349–52. http://dx.doi.org/10.1177/000992289503400702.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Pronicka, Ewa. "Hypocapnic hypothesis of Leigh disease". Medical Hypotheses 101 (abril de 2017): 23–27. http://dx.doi.org/10.1016/j.mehy.2017.01.016.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Geyer, Carl A., K. J. Sartor, A. J. Prensky, C. L. Abramson, F. J. Hodges y M. H. Gado. "Leigh Disease (Subacute Necrotizing Encephalomyelopathy)". Journal of Computer Assisted Tomography 12, n.º 1 (enero de 1988): 40–44. http://dx.doi.org/10.1097/00004728-198801000-00006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Malojcic, Branko, Vesna Brinar, Charles Poser y Visnja Djakovic. "An adult case of Leigh disease". Clinical Neurology and Neurosurgery 106, n.º 3 (junio de 2004): 237–40. http://dx.doi.org/10.1016/j.clineuro.2004.02.028.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Debray, François-Guillaume, Marie Lambert, Pierre Allard y Grant A. Mitchell. "Low Citrulline in Leigh Disease: Still a Biomarker of Maternally Inherited Leigh Syndrome". Journal of Child Neurology 25, n.º 8 (14 de mayo de 2010): 1000–1002. http://dx.doi.org/10.1177/0883073809351983.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Wang, Mei, Ya-Ping Huang, Han Wu, Ke Song, Cong Wan, A.-Ni Chi, Ya-Mei Xiao y Xiao-Yang Zhao. "Mitochondrial complex I deficiency leads to the retardation of early embryonic development in Ndufs4 knockout mice". PeerJ 5 (18 de mayo de 2017): e3339. http://dx.doi.org/10.7717/peerj.3339.

Texto completo

Resumen

Background The NDUFS4 gene encodes an 18-kD subunit of mitochondria complex I, and mutations in this gene lead to the development of a severe neurodegenerative disease called Leigh syndrome (LS) in humans. To investigate the disease phenotypes and molecular mechanisms of Leigh syndrome, the Ndufs4 knockout (KO) mouse has been widely used as a novel animal model. Because the homozygotes cannot survive beyond child-bearing age, whether Ndufs4 and mitochondrial complex I influence early embryonic development remains unknown. In our study, we attempted to investigate embryonic development in Ndufs4 KO mice, which can be regarded as a Leigh disease model and were created through the CRISPR (clustered regularly interspaced short palindromic repeat) and Cas9 (CRISPR associated)-mediated genome editing system. Methods We first designed a single guide RNA (sgRNA) targeting exon 2 of Ndufs4 to delete the NDUFS4 protein in mouse embryos to mimic Leigh syndrome. Then, we described the phenotypes of our mouse model by forced swimming and the open-field test as well as by assessing other behavioral characteristics. Intracytoplasmic sperm injection (ICSI) was performed to obtain KO embryos to test the influence of NDUFS4 deletion on early embryonic development. Results In this study, we first generated Ndufs4 KO mice with physical and behavioral phenotypes similar to Leigh syndrome using the CRISPR/Cas9 system. The low developmental rate of KO embryos that were derived from knockout gametes indicated that the absence of NDUFS4 impaired the development of preimplantation embryos. Discussion In this paper, we first obtained Ndufs4 KO mice that could mimic Leigh syndrome using the CRISPR/Cas9 system. Then, we identified the role of NDUFS4 in early embryonic development, shedding light on its roles in the respiratory chain and fertility. Our model provides a useful tool with which to investigate the function of Ndufs4. Although the pathological mechanisms of the disease need to be discovered, it helps to understand the pathogenesis of NDUFS4 deficiency in mice and its effects on human diseases.

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Ng, Yi Shiau, Ming Lim, Gareth Thomas y Robert McFarland. "Teaching NeuroImages: Neuroradiologic evolution of Leigh disease". Neurology 87, n.º 14 (3 de octubre de 2016): e159-e160. http://dx.doi.org/10.1212/wnl.0000000000003182.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

Sonam, Kothari, P. S. Bindu, Narayanappa Gayathri, Nahid Akhtar Khan, C. Govindaraju, Hanumanthapura R. Arvinda, Madhu Nagappa, Sanjib Sinha, K. Thangaraj y Arun B. Taly. "The “Double Panda” Sign in Leigh Disease". Journal of Child Neurology 29, n.º 7 (18 de abril de 2013): 980–82. http://dx.doi.org/10.1177/0883073813484968.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Paltiel, H. J., A. M. O'Gorman, K. Meagher-Villemure, B. Rosenblatt, K. Silver y G. V. Watters. "Subacute necrotizing encephalomyelopathy (Leigh disease): CT study." Radiology 162, n.º 1 (enero de 1987): 115–18. http://dx.doi.org/10.1148/radiology.162.1.3786750.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Sakushima, Ken, Sachiko Tsuji-Akimoto, Masaaki Niino, Shinji Saitoh, Ichiro Yabe y Hidenao Sasaki. "Adult Leigh Disease Without Failure to Thrive". Neurologist 17, n.º 4 (julio de 2011): 222–27. http://dx.doi.org/10.1097/nrl.0b013e318217357a.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Leigh, P. N., S. Al-Sarraj y S. DiMauro. "Subacute necrotising encephalomyelopathy (Leigh's disease; Leigh syndrome)". Journal of Neurology, Neurosurgery & Psychiatry 86, n.º 4 (13 de enero de 2015): 363–65. http://dx.doi.org/10.1136/jnnp-2012-304601.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Ulualp, Seckin O., Charles G. Wright, Karen Pawlowski y Peter S. Roland. "Cochlear Degeneration in Leigh Disease: Histopathologic Features". Laryngoscope 114, n.º 12 (diciembre de 2004): 2239–42. http://dx.doi.org/10.1097/01.mlg.0000149465.80703.8e.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Coker, Steven B. "Leigh disease presenting as Guillain-Barré syndrome". Pediatric Neurology 9, n.º 1 (enero de 1993): 61–63. http://dx.doi.org/10.1016/0887-8994(93)90013-3.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Danis, Daniel, Katarina Brennerova, Martina Skopkova, Timea Kurdiova, Jozef Ukropec, Juraj Stanik, Miriam Kolnikova y Daniela Gasperikova. "Mutations in SURF1 are important genetic causes of Leigh syndrome in Slovak patients". Endocrine Regulations 52, n.º 2 (1 de abril de 2018): 110–18. http://dx.doi.org/10.2478/enr-2018-0013.

Texto completo

Resumen

AbstractObjectives. Leigh syndrome is a progressive early onset neurodegenerative disease typically presenting with psychomotor regression, signs of brainstem and/or basal ganglia disease, lactic acidosis, and characteristic magnetic resonance imaging findings. At molecular level, deficiency of respiratory complexes and/or pyruvate dehydrogenase complex is usually observed. Nuclear gene SURF1 encodes an assembly factor for cytochrome c-oxidase complex of the respiratory chain and autosomal recessive mutations in SURF1 are one of the most frequent causes of cytochrome c-oxidase-related Leigh syndrome cases. Here, we aimed to elucidate the genetic basis of Leigh syndrome in three Slovak families.Methods and results. Three probands presenting with Leigh syndrome were selected for DNA analysis. The first proband, presenting with atypical LS onset without abnormal basal ganglia magnetic resonance imaging findings, was analyzed with whole exome sequencing. In the two remaining probands, SURF1 was screened by Sanger sequencing. Four different heterozygous mutations were identified in SURF1: c.312_321delinsAT:p.(Pro104Profs*1), c.588+1G>A, c.823_833+7del:p. (?) and c.845_846del:p.(Ser282Cysfs*9). All the mutations are predicted to have a loss-of-function effect.Conclusions. We identified disease-causing mutations in all three probands, which points to the important role of SURF1 gene in etiology of Leigh syndrome in Slovakia. Our data showed that patients with atypical Leigh syndrome phenotype without lesions in basal ganglia may benefit from the whole exome sequencing method. In the case of probands presenting the typical phenotype, Sanger sequencing of the SURF1 gene seems to be an effective method of DNA analysis.

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Bitto, Alessandro. "IS AGING AN ACQUIRED MITOCHONDRIAL DISEASE?" Innovation in Aging 3, Supplement_1 (noviembre de 2019): S394—S395. http://dx.doi.org/10.1093/geroni/igz038.1458.

Texto completo

Resumen

Abstract Mitochondrial dysfunction is a hallmark of aging, but severe mitochondrial dysfunction leads to rare childhood disorders such as Leigh Syndrome. This session explores the similarities and differences between normative aging and mitochondrial disease and the potential for interventions to positively impact both conditions.

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Jabeen, ShaikAfshan, G. Sandeep, KandadaiRukmini Mridula, AngamuttuKanikannan Meena, Rupam Borgohain y Challa Sundaram. "Adult-onset Leigh′s disease: A rare entity". Annals of Indian Academy of Neurology 19, n.º 1 (2016): 140. http://dx.doi.org/10.4103/0972-2327.175437.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

Waldron, Tony. "Edgar Leigh Collis: Industrial lung disease and ergonomics". Journal of Medical Biography 28, n.º 3 (20 de octubre de 2017): 157–62. http://dx.doi.org/10.1177/0967772017735716.

Texto completo

Resumen

Edgar Collis was appointed as the second Medical Inspector of Factories in 1908, holding the post until the outbreak of the First World War when he became Medical Director of the Ministry of Munitions. After the war, he was appointed to the chair in public health in the University of Wales. He held this post while living in Lossiemouth in Scotland, some 570 miles distant. His research interests were in industrial lung disease, industrial hygiene, and the health of coal miners. He made important contributions to the first and third subjects, but was a less significant figure in the field of industrial hygiene. Among his achievements were the recognition of the relationship between silicosis and tuberculosis, the harmful effects of non-silicaceous coal dust, and the need to fit the worker to the job, and the job to the worker.

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Ohama, Eisaku, Fusahiro Ikuta y Nishio Nakamura. "Mitochondrial abnormalities in choroid plexus of leigh disease". Brain and Development 10, n.º 1 (enero de 1988): 30–35. http://dx.doi.org/10.1016/s0387-7604(88)80042-1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Szymanska-Debinska, Tamara, Agnieszka Karkucinska-Wieckowska, Dorota Piekutowska-Abramczuk, Elżbieta Jurkiewicz, Katarzyna Iwanicka-Pronicka, Dariusz Rokicki y Maciej Pronicki. "Leigh disease due toSCO2mutations revealed at extended autopsy". Journal of Clinical Pathology 68, n.º 5 (26 de febrero de 2015): 397–99. http://dx.doi.org/10.1136/jclinpath-2014-202606.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Hoefs, Saskia J. G., Cindy E. J. Dieteren, Felix Distelmaier, Rolf J. R. J. Janssen, Andrea Epplen, Herman G. P. Swarts, Marleen Forkink et al. "NDUFA2 Complex I Mutation Leads to Leigh Disease". American Journal of Human Genetics 82, n.º 6 (junio de 2008): 1306–15. http://dx.doi.org/10.1016/j.ajhg.2008.05.007.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Yamagata, Takanori, Sadayuki Yano, Ichiro Okabe, Masutomo Miyao, Mariko Y. Momoi, Masayoshi Yanagisawa, Hiroko Hirata y Kou Komatsu. "Ultrasonography and magnetic resonance imaging in Leigh disease". Pediatric Neurology 6, n.º 5 (septiembre de 1990): 326–29. http://dx.doi.org/10.1016/0887-8994(90)90025-v.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Sofou, Kalliopi, Irenaeus F. M. de Coo, Elsebet Ostergaard, Pirjo Isohanni, Karin Naess, Linda De Meirleir, Charalampos Tzoulis et al. "Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients". Journal of Medical Genetics 55, n.º 1 (3 de noviembre de 2017): 21–27. http://dx.doi.org/10.1136/jmedgenet-2017-104891.

Texto completo

Resumen

BackgroundLeigh syndrome is a phenotypically and genetically heterogeneous mitochondrial disorder. While some genetic defects are associated with well-described phenotypes, phenotype-genotype correlations in Leigh syndrome are not fully explored.ObjectiveWe aimed to identify phenotype-genotype correlations in Leigh syndrome in a large cohort of systematically evaluated patients.MethodsWe studied 96 patients with genetically confirmed Leigh syndrome diagnosed and followed in eight European centres specialising in mitochondrial diseases.ResultsWe found that ataxia, ophthalmoplegia and cardiomyopathy were more prevalent among patients with mitochondrial DNA defects. Patients with mutations in MT-ND and NDUF genes with complex I deficiency shared common phenotypic features, such as early development of central nervous system disease, followed by high occurrence of cardiac and ocular manifestations. The cerebral cortex was affected in patients with NDUF mutations significantly more often than the rest of the cohort. Patients with the m.8993T>G mutation in MT-ATP6 gene had more severe clinical and radiological manifestations and poorer disease outcome compared with patients with the m.8993T>C mutation.ConclusionOur study provides new insights into phenotype-genotype correlations in Leigh syndrome and particularly in patients with complex I deficiency and with defects in the mitochondrial ATP synthase.

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

Kundu, Gopen Kumar, Amina Akhter, Shaheen Akhter y Md Mizanur Rhaman. "Leigh syndrome: A rare mitochondrial disorder". Bangabandhu Sheikh Mujib Medical University Journal 9, n.º 2 (18 de agosto de 2016): 126. http://dx.doi.org/10.3329/bsmmuj.v9i2.28889.

Texto completo

Resumen

<p>Leigh syndrome is a rare, mitochondrial disorder of childhood . In most cases dysfunction of the respiratory chain enzymes is responsible for the disease. Raised lactate levels in blood and/or cerebrospinal fluid is noted. Magnetic resonance imaging showing characteristic symmetrical necrotic lesions in the basal ganglia and/or brain stem that leads to the appropriate diagnosis. Here, we report a case of progressive neurologic disorders presenting with motor and intellectual regression which on MRI was diagnosed as Leigh syndrome.</p>

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Bugiardini, Enrico, Simon Pope, René G. Feichtinger, Olivia V. Poole, Alan M. Pittman, Cathy E. Woodward, Simon Heales et al. "Utility of Whole Blood Thiamine Pyrophosphate Evaluation in TPK1-Related Diseases". Journal of Clinical Medicine 8, n.º 7 (8 de julio de 2019): 991. http://dx.doi.org/10.3390/jcm8070991.

Texto completo

Resumen

TPK1 mutations are a rare, but potentially treatable, cause of thiamine deficiency. Diagnosis is challenging given the phenotypic overlap that exists with other metabolic and neurological disorders. We report a case of TPK1-related disease presenting with Leigh-like syndrome and review the diagnostic utility of thiamine pyrophosphate (TPP) blood measurement. The proband, a 35-year-old male, presented at four months of age with recurrent episodes of post-infectious encephalopathy. He subsequently developed epilepsy, learning difficulties, sensorineural hearing loss, spasticity, and dysphagia. There was a positive family history for Leigh syndrome in an older brother. Plasma lactate was elevated (3.51 mmol/L) and brain MRI showed bilateral basal ganglia hyperintensities, indicative of Leigh syndrome. Histochemical and spectrophotometric analysis of mitochondrial respiratory chain complexes I, II+III, and IV was normal. Genetic analysis of muscle mitochondrial DNA was negative. Whole exome sequencing of the proband confirmed compound heterozygous variants in TPK1: c. 426G>C (p. Leu142Phe) and c. 258+1G>A (p.?). Blood TPP levels were reduced, providing functional evidence for the deleterious effects of the variants. We highlight the clinical and bioinformatics challenges to diagnosing rare genetic disorders and the continued utility, despite major advances in DNA sequencing technology, of biochemical analyses when investigating novel, potentially disease-causing, genetic variants. Blood TPP measurement represents a fast and cost-effective diagnostic tool in TPK1-related diseases.

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Campolina-Sampaio, Gabriela Palhares, Laura Maria de Lima Belizário Facury Lasmar, Beatriz Silva Vilela Ribeiro y Juliana Gurgel-Giannetti. "The Newcastle Pediatric Mitochondrial Disease Scale: translation and cultural adaptation for use in Brazil". Arquivos de Neuro-Psiquiatria 74, n.º 11 (noviembre de 2016): 909–13. http://dx.doi.org/10.1590/0004-282x20160137.

Texto completo

Resumen

ABSTRACT Objective The aim of this study was to translate and adapt the Newcastle Paediatric Mitochondrial Disease Scale (NPMDS) to Portuguese for use in Brazil. Methods The scale was applied in 20 pediatric patients with mitochondrial disease, in three groups: myopathy (n = 4); Leigh syndrome (n = 8); and encephalomyopathy (n = 8). Scores were obtained for the various dimensions of the NPMDS, and comparisons were drawn between the groups. Results There was a statistically significant difference between the myopathy group and the Leigh syndrome group (p = 0.0085), as well as between the myopathy and encephalomyopathy groups (p = 0.01). Conclusions The translation of the NPMDS, and its adaptation to the socioeconomic and cultural conditions in Brazil, make the NPMDS score useful as an additional parameter in the evaluation and monitoring of pediatric patients with MD in Brazil.

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Itkis⁎, Yulia S., Galina E. Rudenskaya, Polina G. Tsygankova, Ekaterina Y. Zakharova y Svetlana V. Mikhailova. "Mitochondrial DNA mutations in cases of Leigh-like disease". Mitochondrion 11, n.º 4 (julio de 2011): 647. http://dx.doi.org/10.1016/j.mito.2011.03.040.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Rahman, J., A. Noronha, I. Thiele y S. Rahman. "Leigh Map: a novel diagnostic resource for mitochondrial disease". Neuromuscular Disorders 27 (marzo de 2017): S19. http://dx.doi.org/10.1016/s0960-8966(17)30274-2.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Araki, Satoshi, Masaharu Hayashi, Atsushi Yasaka y Kiyo Maruki. "Electrophysiological brainstem dysfunction in a child with Leigh disease". Pediatric Neurology 16, n.º 4 (mayo de 1997): 329–33. http://dx.doi.org/10.1016/s0887-8994(97)00020-9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Surana, P., S. Patni y B. Hargitai. "G383 Perinatal leigh disease masquerading as hypoxic ischaemic encephalopathy". Archives of Disease in Childhood 101, Suppl 1 (abril de 2016): A222.2—A223. http://dx.doi.org/10.1136/archdischild-2016-310863.373.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

31

Laird, Philip W., Brian G. Mohney y Deborah L. Renaud. "Bull’s-Eye Maculopathy in an Infant With Leigh Disease". American Journal of Ophthalmology 142, n.º 1 (julio de 2006): 186–87. http://dx.doi.org/10.1016/j.ajo.2006.02.051.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

32

Greenberg, S. B., E. N. Faerber, J. J. Riviello, G. de Leon y M. A. Capitanio. "Subacute necrotizing encephalomyelopathy (Leigh disease): CT and MRI appearances". Pediatric Radiology 21, n.º 1 (diciembre de 1990): 5–8. http://dx.doi.org/10.1007/bf02010803.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

33

de Haas, Ria, Frans G. Russel y Jan A. Smeitink. "Gait analysis in a mouse model resembling Leigh disease". Behavioural Brain Research 296 (enero de 2016): 191–98. http://dx.doi.org/10.1016/j.bbr.2015.09.006.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

34

Vogel, Hannes. "Burden of Proof in the Postmortem Diagnosis of Mitochondrial Disease: Leigh Disease". Pediatric and Developmental Pathology 7, n.º 6 (noviembre de 2004): 615–19. http://dx.doi.org/10.1007/s10024-004-5054-1.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

35

Hombal, AG y VN Narvekar. "Leigh′s disease (subacute necrotising encephalo-myelopathy)-a case report". Indian Journal of Radiology and Imaging 15, n.º 2 (2005): 217. http://dx.doi.org/10.4103/0971-3026.28806.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

36

Diab, M. "Self-inflicted orodental injury in a child with Leigh disease". International Journal of Paediatric Dentistry 14, n.º 1 (enero de 2004): 73–77. http://dx.doi.org/10.1111/j.1365-263x.2004.00472.x.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

37

Terkawi, AbdullahSulieman, KhalidM Al-Shuaibi, TariqM Wani y JosephD Tobias. "Anesthetic considerations in Leigh disease: Case report and literature review". Saudi Journal of Anaesthesia 6, n.º 2 (2012): 181. http://dx.doi.org/10.4103/1658-354x.97037.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

38

Rahman, Joyeeta, Alberto Noronha, Ines Thiele y Shamima Rahman. "Leigh map: A novel computational diagnostic resource for mitochondrial disease". Annals of Neurology 81, n.º 1 (enero de 2017): 9–16. http://dx.doi.org/10.1002/ana.24835.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

39

Wasniewska, Magdalena, Elzbieta Karczmarewicz, Maciej Pronicki, Dorota Piekutowska-Abramczuk, Krzysztof Zabłocki, Ewa Popowska, Ewa Pronicka y Jerzy Duszyński. "Abnormal Calcium Homeostasis in Fibroblasts from Patients with Leigh Disease". Biochemical and Biophysical Research Communications 283, n.º 3 (mayo de 2001): 687–93. http://dx.doi.org/10.1006/bbrc.2001.4834.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

40

Taylor, Robert W., Andrew AM Morris, Michael Hutchinson y Douglass M. Turnbull. "Leigh disease associated with a novel mitochondrial DNA ND5 mutation". European Journal of Human Genetics 10, n.º 2 (febrero de 2002): 141–44. http://dx.doi.org/10.1038/sj.ejhg.5200773.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

41

Stendel, Claudia, Christiane Neuhofer, Elisa Floride, Shi Yuqing, Rebecca D. Ganetzky, Joohyun Park, Peter Freisinger et al. "Delineating MT-ATP6-associated disease". Neurology Genetics 6, n.º 1 (13 de enero de 2020): e393. http://dx.doi.org/10.1212/nxg.0000000000000393.

Texto completo

Resumen

ObjectiveTo delineate the phenotypic and genotypic spectrum in carriers of mitochondrial MT-ATP6 mutations in a large international cohort.MethodsWe analyzed in detail the clinical, genetical, and neuroimaging data from 132 mutation carriers from national registries and local databases from Europe, USA, Japan, and China.ResultsWe identified 113 clinically affected and 19 asymptomatic individuals with a known pathogenic MT-ATP6 mutation. The most frequent mutations were m.8993 T > G (53/132, 40%), m.8993 T > C (30/132, 23%), m.9176 T > C (30/132, 23%), and m.9185 T > C (12/132, 9%). The degree of heteroplasmy was high both in affected (mean 95%, range 20%–100%) and unaffected individuals (mean 73%, range 20%–100%). Age at onset ranged from prenatal to the age of 75 years, but almost half of the patients (49/103, 48%) became symptomatic before their first birthday. In 28 deceased patients, the median age of death was 14 months. The most frequent symptoms were ataxia (81%), cognitive dysfunction (49%), neuropathy (48%), seizures (37%), and retinopathy (14%). A diagnosis of Leigh syndrome was made in 55% of patients, whereas the classic syndrome of neuropathy, ataxia, and retinitis pigmentosa (NARP) was rare (8%).ConclusionsIn this currently largest series of patients with mitochondrial MT-ATP6 mutations, the phenotypic spectrum ranged from asymptomatic to early onset multisystemic neurodegeneration. The degree of mutation heteroplasmy did not reliably predict disease severity. Leigh syndrome was found in more than half of the patients, whereas classic NARP syndrome was rare. Oligosymptomatic presentations were rather frequent in adult-onset patients, indicating the need to include MT-ATP6 mutations in the differential diagnosis of both ataxias and neuropathies.

Los estilos APA, Harvard, Vancouver, ISO, etc.

42

Speer, Rebecca R., Uzoamaka C. Ezeanya, Sarah J. Beaudoin, Kristen M. Glass y Christiana N. Oji-Mmuo. "Term Neonate Presenting with the Combined Occurrence of Mucolipidosis Type II and Leigh Syndrome". Journal of Pediatric Genetics 09, n.º 02 (24 de octubre de 2019): 137–41. http://dx.doi.org/10.1055/s-0039-1700519.

Texto completo

Resumen

AbstractMucolipidosis II α/beta (MLII) is an autosomal recessive disease in which a gene mutation leads to improper targeting of lysosomal enzymes with an end result of accumulation of lysosomes in the mitochondria resulting in a dysfunctional mitochondria.1 Leigh syndrome (LS) is a rare progressive neurodegenerative disorder associated with dysfunctional mitochondria and oxidative phosphorylation.4 Both disease processes typically present in infancy.3 7 Herein, we present a case of an infant diagnosed with both mucolipidosis II and Leigh syndrome. Genetic analysis in this case revealed two mutations (NDUFA12 c.178C > T p.Arg60* and GNPTAB c.732_733delAA) on the long arm of chromosome 12 as the etiology of MLII and LS in this neonate, respectively. We are unaware of any previously published cases of the presence of these two diseases occurring in the same patient. The complex clinical presentation of this case led to a delay in the diagnosis, and we believe that the clinical phenotypes of these two conditions were likely worsened. The genetic alterations presented in this case occurred as a result of mutations on chromosome 12. We suggest further investigation into the potential overlap in the pathophysiology, specifically the inheritance pattern, linkage disequilibrium, mitochondrial–lysosomal interaction, or crosstalk contributing to both diseases.

Los estilos APA, Harvard, Vancouver, ISO, etc.

43

Bitto, Alessandro, Anthony Grillo y Matt Kaeberlein. "Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh Syndrome". Innovation in Aging 4, Supplement_1 (1 de diciembre de 2020): 886. http://dx.doi.org/10.1093/geroni/igaa057.3271.

Texto completo

Resumen

Abstract Mitochondrial diseases are pathologies characterized by impairment in mitochondrial function. Mitochondrial dysfunction is also a hallmark of the aging process. Rapamycin, a drug that increases lifespan and reduces the incidence of age-related pathologies in multiple models, increases survival and reduces the impact of neurological symptoms in a mouse model lacking the complex I subunit Ndufs4. Here we show that acarbose, another drug that extends lifespan in mice, suppresses symptoms of disease and improves survival of Ndufs4-/- mice. Unlike rapamycin, acarbose rescues disease phenotypes independently of mTOR inhibition. Furthermore, rapamycin and acarbose have additive effects on clasping and maximum lifespan in Ndufs4-/- mice. Acarbose rescues mitochondrial disease independently of glycolytic flux and Sirt3 activity by potentially remodeling the microbiome. This study provides the first evidence that the microbiome may rescue severe mitochondrial disease and proof of principle that biological aging and mitochondrial disorders are driven by common mechanisms.

Los estilos APA, Harvard, Vancouver, ISO, etc.

44

Ellis, Zachary y Charles Bloomer. "Outpatient Anesthesia for Oral Surgery in a Juvenile With Leigh Disease". Anesthesia Progress 52, n.º 2 (junio de 2005): 70–73. http://dx.doi.org/10.2344/0003-3006(2005)52[70:oafosi]2.0.co;2.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

45

Baker, P. R., M. Friederich, C. Rice, L. J. Wong y J. Van Hove⁎. "ND3 Mutation 10191T>C causes rapidly progressive infantile Leigh disease". Mitochondrion 11, n.º 4 (julio de 2011): 669–70. http://dx.doi.org/10.1016/j.mito.2011.03.099.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

46

Jiang, Yu-Wu, Jiong Qin, Yun Yuan, Yu Qi y Xi-Ru Wu. "Neuropathologic and Clinical Features in Eight Chinese Patients With Leigh Disease". Journal of Child Neurology 17, n.º 6 (junio de 2002): 450–52. http://dx.doi.org/10.1177/088307380201700611.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

47

Acer, H., M. Canpolat, G. K. Özçora y S. Kumandaş. "A familial case of Leigh Disease related to NDUFV1 homozygous mutations". European Journal of Paediatric Neurology 21 (junio de 2017): e133-e134. http://dx.doi.org/10.1016/j.ejpn.2017.04.1031.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

48

Koch, Thomas K., Warren D. Lo y Bruce O. Berg. "Variability of serial CT scans in subacute necrotizing encephalomyelopathy (leigh disease)". Pediatric Neurology 1, n.º 1 (enero de 1985): 48–51. http://dx.doi.org/10.1016/0887-8994(85)90009-8.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

49

Craigen, William J. "Leigh disease with deficiency of lipoamide dehydrogenase: Treatment failure with dichloroacetate". Pediatric Neurology 14, n.º 1 (enero de 1996): 69–71. http://dx.doi.org/10.1016/0887-8994(96)00005-7.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

50

Khailany, Rozhgar A., Naser Gilani, Mehmet Ozaslan, Muhamad Safdar, Ihsan Al-Shamari, Belan O. Kanabe, Khandakar A. S. M. Saadat et al. "Association of a point mutation (m.9176T>G) of the MT-ATP6 gene with Leigh syndrome: A case report". Biomedical Research and Therapy 7, n.º 5 (25 de mayo de 2020): 3739–43. http://dx.doi.org/10.15419/bmrat.v7i5.601.

Texto completo

Resumen

Leigh Syndrome (LS) is an uncommon progressive neurodegenerative mitochondrial disorder. The condition is characterized by progressive mental and developmental disabilities (psychomotor regression) and commonly brings about death within a few years of diagnosis, more often due to respiratory failure. In a small number of patients the disorder does not manifest until adulthood. The principal indications of Leigh syndrome found in early stages typically are diarrhea, vomiting, and difficulty swallowing (dysphagia), which disturbs eating. These problems usually result in powerlessness to develop and put on weight under the normal rate (failure to thrive). Serious movement and muscle problems are basic in Leigh syndrome. In this case report, we introduce the molecular and clinical features of a 19-year-old female as proband, and also, we study other members of the family consequently. The m.9176T>G heteroplasmic mutation in the MT-ATP6 gene was detected by high-resolution melt (HRM) and DNA sequencing techniques. Similarly, the m.9176T>G was heteroplasmic in the mother. In conclusion, this report in compliance with previous studies underlines the necessity of further research on prenatal distinguishing proof of the responsible mutations and avoidance of the disease in families with known cases.

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!